Ken Cardona leads EA7211/STRASS 2 clinical trial: A randomized study in retroperitoneal sarcoma – ECOG-ACRIN Cancer Research Group

ECOG-ACRIN Cancer Research Group, shared a post on X:

“Clinical Trial EA7211/STRASS 2, led in the US by Ken Cardona, is the second randomized study ever performed in retroperitoneal soft tissue sarcoma and is enrolling patients in the US, Europe, Canada, Australia, New Zealand, and Japan!”

Ken Cardona

A Randomized Study Investigating Preoperative Chemotherapy Followed by Surgery versus Surgery Alone in Patients with High Risk Retroperitoneal Sarcoma, STRASS2 Trial

Ken Cardona

Learn more about retroperitoneal sarcoma on OncoDaily.

Insight

cancer clinical trial ECOG-ACRIN Cancer Research Group Ken Cardona Kenneth Cardona OncoDaily Oncology retroperitoneal sarcoma sarcoma